← Back to Search

Telenovela Intervention for HIV Prevention in Latinas

N/A
Recruiting
Led By Natalia A Villegas Rodriguez, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 7 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will develop and test a novel online "telenovela" intervention targeting Latinas in the US, to reduce HIV disparities and increase HIV prevention.

Who is the study for?
This trial is for self-identified Latinas, aged 18-44, living in North Carolina who are sexually active with men and have internet access. They must be fluent in English or Spanish and assigned female at birth.
What is being tested?
The study tests an online telenovela-style intervention called 'Infección de Amor' aimed at improving HIV prevention behaviors among Latinas. It will compare changes in condom use, HIV testing, and PrEP awareness between participants watching the episodes and a control group over seven months.
What are the potential side effects?
Since this intervention involves educational content delivered through a soap opera format rather than a medical treatment, there are no direct physical side effects associated with participating in this clinical trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 7 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Condom Use from Baseline to Month 1
Change in Condom Use from Baseline to Month 7
Change in HIV Test Perception from Baseline to Month 1
+9 more
Secondary study objectives
Change in Depression
Change in Emotional Response
Change in Intimate Partner Violence (IPV)
+11 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wait-listedExperimental Treatment1 Intervention
A wait-listed control group of 71 Latinas will receive IA in the same manner as the intervention group. Latinas will start watching the telenovela episodes 7 months after their baseline survey (after T3 survey). Latinas will be informed at recruitment of this group condition and the study randomization. During the waiting time, participants will be called on a monthly basis to encourage participation and refer to services if needed.
Group II: Infección de Amor (Infectious Love)Experimental Treatment1 Intervention
71 Latinas will view four IA intervention episodes, one per week immediately after the baseline survey and orientation. Participants will receive an email to their preferred email address with a password to access to the episode on the IA's website: www.telenoveladeamor.com Each 10-minute episode can be watched more than once during the week and presents a situation with notable HIV risk and ways the characters avoided risk (e.g., condom use) or confronted consequences of poor practices (e.g., HIV infection). The one week time frame for each episode is needed to provide time to review and reflect about IA's content and modify HIV prevention behaviors. It will also allow Latinas to obtain information and support from the team and referral if needed. This time frame was effective to improve behaviors in previous studies.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,568 Previous Clinical Trials
4,301,942 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,605 Previous Clinical Trials
3,329,776 Total Patients Enrolled
Natalia A Villegas Rodriguez, PhDPrincipal InvestigatorUniversity of North Carolina at Chapel Hill School of Nursing

Media Library

Infección de Amor (Infectious Love) Clinical Trial Eligibility Overview. Trial Name: NCT05929482 — N/A
HIV Suppression Research Study Groups: Infección de Amor (Infectious Love), Wait-listed
HIV Suppression Clinical Trial 2023: Infección de Amor (Infectious Love) Highlights & Side Effects. Trial Name: NCT05929482 — N/A
Infección de Amor (Infectious Love) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05929482 — N/A
~59 spots leftby Dec 2025